本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2024/9/231 分钟阅读
Progynon Associates, et al.; Withdrawal of Approval of Four New Drug Applications
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing approval of four new drug applications (NDAs) from multiple holders of those NDAs. The basis for the withdrawal is that these NDA holders have repeatedly failed to file required annual reports for the identified NDAs.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →